The global pharmaceutical and nutraceutical markets are witnessing a paradigm shift in how we approach Red Blood Cell (RBC) production—scientifically known as erythropoiesis. As a leading manufacturer and factory network, we recognize that blood health is no longer just about iron supplementation; it is a complex biological symphony requiring high-purity peptides, plant-derived bioactive compounds, and advanced PDRN (Polydeoxyribonucleotide) technology.
Industry data suggests that the erythropoietin stimulating agents market is projected to grow at a CAGR of 6.2%, driven by an aging global population and a rising prevalence of chronic conditions. Our role as a "Discount Manufacturer" does not imply a compromise on quality, but rather an optimization of the supply chain through Shaanxi Bieyouth Biotech's massive 50,000-ton annual capacity, bringing down the cost of life-saving raw materials for global distributors.
Through our GMP-certified facilities, we bridge the gap between complex biotechnology and commercial viability. Our technical roadmap focuses on the synthesis of precursors that stimulate natural erythropoietin (EPO) production, utilizing green extraction technologies that minimize environmental impact while maximizing biological efficacy.
Utilizing CRISPR-inspired screening to identify plant peptides that mimic human hematopoietic growth factors. Our 30+ scientific breakthroughs pave the way for non-synthetic blood health solutions.
Implementation of AI-driven fermentation and extraction controls. Our factory uses real-time sensors to ensure 99% purity in pharmaceutical-grade extracts like Ferulic Acid and Licorice PDRN.
Addressing regional needs—from high-altitude hypoxia management in Central Asia to sports performance optimization in North America. Custom OEM formulations tailored to specific regulatory climates.
5-level quality control encompassing HPLC, GC, and microbiological testing. We ensure every batch meets FDA and GMP standards before crossing international borders.
Transitioning from supplement-based support to regenerative medicine. Exploring the synergy between Dipeptides and erythropoiesis for accelerated recovery cycles.
Green tech extraction using CO2 supercritical methods, reducing solvent waste by 85% compared to traditional chemical factories.
Shaanxi Bieyouth Biotech Co., Ltd. was established in 2018, with too many years of experience in foreign trade import and export. It is a large-scale gold supplier integrating production and sales. We mainly do plant and animal extracts, food additives, cosmetic raw materials and pharmaceutical raw materials. Our production facilities are GMP certified, with two standardized production workshops and advanced extraction equipment.
Our raw materials are integral to producing therapeutic agents for renal anemia and oncology support. By optimizing the production of precursors, we help pharmaceutical companies reduce the "cost-per-dose" while maintaining high therapeutic indexes.
The "Clean Label" trend is driving demand for vegan-friendly nutrient boosters. Our Oat Peptides and Rice Germ Powders serve as the foundation for the next generation of blood-supporting dietary supplements.
Participated in Shanghai International Cosmetics and Raw Materials exhibition, showcasing advanced hematological precursors.
Obtained FDA certificate, cementing our position as a globally recognized manufacturer.
Launched global foreign trade business and established the Institute of Biology for cosmetic and pharmaceutical research.
Awarded "Integrity Enterprise" and "Quality Assured Enterprise" titles.
In-depth discussions to understand product specifications, quality benchmarks, and volume expectations.
Leveraging our expertise to create unique formulations or producing according to provided designs.
Prototyping for client approval, ensuring standard alignment before mass production.
Mass production under strict GMP controls and global delivery to the US, UK, Canada, Russia, and Australia.
Bieyouth
